These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 17200151)
1. SGCE missense mutations that cause myoclonus-dystonia syndrome impair epsilon-sarcoglycan trafficking to the plasma membrane: modulation by ubiquitination and torsinA. Esapa CT; Waite A; Locke M; Benson MA; Kraus M; McIlhinney RA; Sillitoe RV; Beesley PW; Blake DJ Hum Mol Genet; 2007 Feb; 16(3):327-42. PubMed ID: 17200151 [TBL] [Abstract][Full Text] [Related]
2. A gain-of-glycosylation mutation associated with myoclonus-dystonia syndrome affects trafficking and processing of mouse ε-sarcoglycan in the late secretory pathway. Waite A; De Rosa MC; Brancaccio A; Blake DJ Hum Mutat; 2011 Nov; 32(11):1246-58. PubMed ID: 21796726 [TBL] [Abstract][Full Text] [Related]
3. Epsilon sarcoglycan mutations and phenotype in French patients with myoclonic syndromes. Tezenas du Montcel S; Clot F; Vidailhet M; Roze E; Damier P; Jedynak CP; Camuzat A; Lagueny A; Vercueil L; Doummar D; Guyant-Maréchal L; Houeto JL; Ponsot G; Thobois S; Cournelle MA; Durr A; Durif F; Echenne B; Hannequin D; Tranchant C; Brice A; J Med Genet; 2006 May; 43(5):394-400. PubMed ID: 16227522 [TBL] [Abstract][Full Text] [Related]
4. Earlier onset of motor deficits in mice with double mutations in Dyt1 and Sgce. Yokoi F; Yang G; Li J; DeAndrade MP; Zhou T; Li Y J Biochem; 2010 Oct; 148(4):459-66. PubMed ID: 20627944 [TBL] [Abstract][Full Text] [Related]
5. Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome. Zimprich A; Grabowski M; Asmus F; Naumann M; Berg D; Bertram M; Scheidtmann K; Kern P; Winkelmann J; Müller-Myhsok B; Riedel L; Bauer M; Müller T; Castro M; Meitinger T; Strom TM; Gasser T Nat Genet; 2001 Sep; 29(1):66-9. PubMed ID: 11528394 [TBL] [Abstract][Full Text] [Related]
8. Japanese familial case of myoclonus-dystonia syndrome with a splicing mutation in SGCE. Wada T; Takano K; Tsurusaki Y; Miyake N; Nakashima M; Saitsu H; Matsumoto N; Osaka H Pediatr Int; 2015 Apr; 57(2):324-6. PubMed ID: 25868953 [TBL] [Abstract][Full Text] [Related]
9. Analysis of the epsilon-sarcoglycan gene in familial and sporadic myoclonus-dystonia: evidence for genetic heterogeneity. Valente EM; Misbahuddin A; Brancati F; Placzek MR; Garavaglia B; Salvi S; Nemeth A; Shaw-Smith C; Nardocci N; Bentivoglio AR; Berardelli A; Eleopra R; Dallapiccola B; Warner TT Mov Disord; 2003 Sep; 18(9):1047-51. PubMed ID: 14502674 [TBL] [Abstract][Full Text] [Related]
10. Severe myoclonus-dystonia syndrome associated with a novel epsilon-sarcoglycan gene truncating mutation. Maréchal L; Raux G; Dumanchin C; Lefebvre G; Deslandre E; Girard C; Campion D; Parain D; Frebourg T; Hannequin D Am J Med Genet B Neuropsychiatr Genet; 2003 May; 119B(1):114-7. PubMed ID: 12707948 [TBL] [Abstract][Full Text] [Related]
11. SGCZ mutations are unlikely to be associated with myoclonus dystonia. Peall KJ; Ritz K; Waite AJ; Groen JL; Morris HR; Baas F; Blake DJ; Tijssen MA Neuroscience; 2014 Jul; 272():88-91. PubMed ID: 24792710 [TBL] [Abstract][Full Text] [Related]
12. Screening for SGCE mutations in Moroccan sporadic patients with Myoclonus-Dystonia syndrome. Rachad L; El Otmani H; Karkar A; El Moutawakil B; El Kadmiri N; Nadifi S Neurosci Lett; 2019 Jun; 703():1-4. PubMed ID: 30849405 [TBL] [Abstract][Full Text] [Related]
13. The epsilon-sarcoglycan gene in myoclonic syndromes. Valente EM; Edwards MJ; Mir P; DiGiorgio A; Salvi S; Davis M; Russo N; Bozi M; Kim HT; Pennisi G; Quinn N; Dallapiccola B; Bhatia KP Neurology; 2005 Feb; 64(4):737-9. PubMed ID: 15728306 [TBL] [Abstract][Full Text] [Related]
14. Myoclonus-dystonia syndrome: epsilon-sarcoglycan mutations and phenotype. Asmus F; Zimprich A; Tezenas Du Montcel S; Kabus C; Deuschl G; Kupsch A; Ziemann U; Castro M; Kühn AA; Strom TM; Vidailhet M; Bhatia KP; Dürr A; Wood NW; Brice A; Gasser T Ann Neurol; 2002 Oct; 52(4):489-92. PubMed ID: 12325078 [TBL] [Abstract][Full Text] [Related]
15. Abnormal nuclear envelopes in the striatum and motor deficits in DYT11 myoclonus-dystonia mouse models. Yokoi F; Dang MT; Zhou T; Li Y Hum Mol Genet; 2012 Feb; 21(4):916-25. PubMed ID: 22080833 [TBL] [Abstract][Full Text] [Related]
16. Mutation in ε-Sarcoglycan Induces a Myoclonus-Dystonia Syndrome-Like Movement Disorder in Mice. Li J; Liu Y; Li Q; Huang X; Zhou D; Xu H; Zhao F; Mi X; Wang R; Jia F; Xu F; Yang J; Liu D; Deng X; Zhang Y Neurosci Bull; 2021 Mar; 37(3):311-322. PubMed ID: 33355901 [TBL] [Abstract][Full Text] [Related]
17. Twenty years on: Myoclonus-dystonia and ε-sarcoglycan - neurodevelopment, channel, and signaling dysfunction. Menozzi E; Balint B; Latorre A; Valente EM; Rothwell JC; Bhatia KP Mov Disord; 2019 Nov; 34(11):1588-1601. PubMed ID: 31449710 [TBL] [Abstract][Full Text] [Related]
18. Gait Impairment in Myoclonus-Dystonia (DYT- Haeri G; Shahidi G; Fasano A; Rohani M Tremor Other Hyperkinet Mov (N Y); 2019; 9():. PubMed ID: 31413899 [TBL] [Abstract][Full Text] [Related]
19. [Clinical and genetic analysis of childhood-onset myoclonus dystonia syndrome caused by SGCE variants]. Tian XJ; Ding CH; Zhang YH; Dai LF; Chen CH; Li JW; Wang X; Han TL; Wang XH; Deng J Zhonghua Er Ke Za Zhi; 2020 Feb; 58(2):123-128. PubMed ID: 32102149 [No Abstract] [Full Text] [Related]
20. A novel SGCE variant is associated with myoclonus-dystonia with phenotypic variability. Delgado-Alvarado M; Matilla-Dueñas A; Altadill-Bermejo A; Setién S; Misiego-Peral M; Sánchez-de la Torre JR; Corral-Juan M; Riancho J Neurol Sci; 2020 Dec; 41(12):3779-3781. PubMed ID: 32955639 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]